Details of the Competitor
General Information of Competitor
The Competitor Interaction Atlas
Probe(s) Related This Competitor
PAL-AfBPP Probe
| Probe Name | Structure | Concentration | Cell-system | Ref | |
|---|---|---|---|---|---|
|
Kambe_8 Probe Info |
![]() |
10 uM | Human prostate carcinoma cells (PC-3) | [1] | |
|
Kambe_22 Probe Info |
![]() |
10 uM | Human prostate carcinoma cells (PC-3) | [1] | |
|
Kambe_24 Probe Info |
![]() |
10 uM | Human prostate carcinoma cells (PC-3) | [1] | |
|
Kambe_26 Probe Info |
![]() |
10 uM | Human prostate carcinoma cells (PC-3) | [1] | |
|
Kambe_31 Probe Info |
![]() |
10 uM | Human prostate carcinoma cells (PC-3) | [1] | |
|
Kambe_55 Probe Info |
![]() |
10 uM | Human prostate carcinoma cells (PC-3) | [1] | |
Target(s) List of this Competitor
|
17 Enzyme Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1 Transporter and channel Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
10 Other Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Information of The Labelling Profiles of This Competitor
Kambe_22
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cells (PC-3) | ||||
| Interaction Atlas ID |
|
|||
Kambe_24
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cells (PC-3) | ||||
| Interaction Atlas ID |
|
|||
Kambe_26
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cells (PC-3) | ||||
| Interaction Atlas ID |
|
|||
Kambe_31
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cells (PC-3) | ||||
| Interaction Atlas ID |
|
|||
Kambe_55
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cells (PC-3) | ||||
| Interaction Atlas ID |
|
|||
Kambe_8
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cells (PC-3) | ||||
| Interaction Atlas ID |
|
|||






